Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Tag Archives: Canada
H1N1 Vaccine Quantities to Fall Short of Predictions
Image by â– Guerry via Flickr
The US may not have as many H1N1 flu vaccines available from the get-go as originally anticipated, CBS News reported on Tuesday.
According to the report, approximately 45 million doses will be available in mid-October—that’s down from the original plan of 120 million doses. The new plan calls for [...]
Posted in Manufacturing Also tagged GlaxoSmithKline, Health, Influenza, Influenza A virus subtype H1N1, Influenza pandemic, Influenza vaccine 2 Comments
GSK Signs $120M Deal to Market DMab Overseas
Image via Wikipedia
In an effort to boost its sales force without hiring more sales reps, Amgen announced on Tuesday that it has signed a deal with GlaxoSmithKline to co-market its osteoporosis treatment denosumab—currently pending FDA approval.
GSK will paying $120 million up front (along with royalties) to mutually market denosumab, or DMab, in regions where Amgen [...]
Posted in Deals, News, Technology Also tagged Amgen, Australia, denosumab, Dmab, GlaxoSmithKline, Market, Mexico, New Zealand, sales force, U.S. Food and Drug Administration, United States Leave a comment

Pharma Unplugged #2 Layoffs & Bonuses